Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis

IMPORTANCE: Precise estimation of the drug metabolism capacity for individual patients is crucial for adequate dose personalization. OBJECTIVE: To quantify the difference in the antipsychotic and antidepressant exposure among patients with genetically associated CYP2C19 and CYP2D6 poor (PM), interme...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Psychiatry
Autors principals: Milosavljević, Filip, Bukvić, Nikola, Pavlović, Zorana, Miljević, Čedo, Pešić, Vesna, Molden, Espen, Ingelman-Sundberg, Magnus, Leucht, Stefan, Jukić, Marin M.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2020
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7702196/
https://ncbi.nlm.nih.gov/pubmed/33237321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapsychiatry.2020.3643
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars